Mark A. Stephenson

660 total citations
9 papers, 562 citations indexed

About

Mark A. Stephenson is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Mark A. Stephenson has authored 9 papers receiving a total of 562 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pulmonary and Respiratory Medicine, 4 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Mark A. Stephenson's work include RNA modifications and cancer (3 papers), Cancer-related Molecular Pathways (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Mark A. Stephenson is often cited by papers focused on RNA modifications and cancer (3 papers), Cancer-related Molecular Pathways (3 papers) and Lung Cancer Treatments and Mutations (3 papers). Mark A. Stephenson collaborates with scholars based in United States, Jordan and India. Mark A. Stephenson's co-authors include Margaret Gondo, Richard W. Brown, Mamoun Younes, Philip T. Cagle, Philip T. Cagle, Eunhee S. Yi, Rose C. Anton, Donna Coffey, Alberto M. Marchevsky and William F. Benedict and has published in prestigious journals such as Cancer, Human Pathology and Modern Pathology.

In The Last Decade

Mark A. Stephenson

9 papers receiving 549 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark A. Stephenson United States 8 272 237 207 193 114 9 562
R. Molina Spain 9 251 0.9× 299 1.3× 163 0.8× 240 1.2× 108 0.9× 16 689
M. Koukourakis Greece 12 284 1.0× 227 1.0× 125 0.6× 125 0.6× 96 0.8× 28 563
Kristina Lamberg Sweden 13 194 0.7× 414 1.7× 427 2.1× 139 0.7× 68 0.6× 20 789
Stephen Raskin Israel 10 243 0.9× 157 0.7× 84 0.4× 146 0.8× 83 0.7× 31 607
Jie‐Tao Ma China 15 198 0.7× 311 1.3× 364 1.8× 153 0.8× 96 0.8× 43 677
M. Ebert Germany 11 240 0.9× 328 1.4× 271 1.3× 189 1.0× 109 1.0× 17 732
Keiichi Honma Japan 12 175 0.6× 205 0.9× 271 1.3× 190 1.0× 82 0.7× 29 621
Martin Rees United Kingdom 11 460 1.7× 490 2.1× 111 0.5× 230 1.2× 52 0.5× 17 973
Adi Gazdar United States 10 377 1.4× 227 1.0× 172 0.8× 135 0.7× 53 0.5× 15 670
Lucia Trandafir Switzerland 11 280 1.0× 247 1.0× 272 1.3× 85 0.4× 56 0.5× 22 634

Countries citing papers authored by Mark A. Stephenson

Since Specialization
Citations

This map shows the geographic impact of Mark A. Stephenson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Stephenson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Stephenson more than expected).

Fields of papers citing papers by Mark A. Stephenson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark A. Stephenson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Stephenson. The network helps show where Mark A. Stephenson may publish in the future.

Co-authorship network of co-authors of Mark A. Stephenson

This figure shows the co-authorship network connecting the top 25 collaborators of Mark A. Stephenson. A scholar is included among the top collaborators of Mark A. Stephenson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark A. Stephenson. Mark A. Stephenson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Sawair, Faleh, Yazan Hassona, C. Irwin, et al.. (2016). p53, Cyclin D1, p21 (WAF1) and Ki-67 (MIB1) Expression at Invasive Tumour Fronts of Oral Squamous Cell Carcinomas and Development of Local Recurrence. Asian Pacific Journal of Cancer Prevention. 17(3). 1243–1249. 9 indexed citations
2.
Castro, Claudia Y., Mark A. Stephenson, Margaret Gondo, L. Jeffrey Medeiros, & Philip T. Cagle. (2000). Prognostic Implications Of Calbindin-D28k Expression in Lung Cancer: Analysis of 452 Cases. Modern Pathology. 13(7). 808–813. 8 indexed citations
3.
Anton, Rose C., Donna Coffey, Margaret Gondo, et al.. (2000). The Expression of Cyclins D1 and E in Predicting Short-Term Survival in Squamous Cell Carcinoma of the Lung. Modern Pathology. 13(11). 1167–1172. 22 indexed citations
4.
Marchevsky, Alberto M., Mark A. Stephenson, Margaret Gondo, et al.. (1998). Artificial neural networks and logistic regression as tools for prediction of survival in patients with Stages I and II non-small cell lung cancer.. PubMed. 11(7). 618–25. 30 indexed citations
6.
Younes, Mamoun, Richard W. Brown, Mark A. Stephenson, Margaret Gondo, & Philip T. Cagle. (1997). Overexpression of glut1 and glut3 in stage I nonsmall cell lung carcinoma is Associated with poor survival. Cancer. 80(6). 1046–1051. 333 indexed citations
7.
Anton, Rose C., Richard W. Brown, Mamoun Younes, et al.. (1997). Absence of prognostic significance of bcl-2 immunopositivity in non-small cell lung cancer: Analysis of 427 cases. Human Pathology. 28(9). 1079–1082. 45 indexed citations
8.
Yi, Eunhee S., Margaret Gondo, Mark A. Stephenson, et al.. (1997). High c-erbB-3 protein expression is associated with shorter survival in advanced non-small cell lung carcinomas.. PubMed. 10(2). 142–8. 107 indexed citations
9.
Stephenson, Mark A., et al.. (1992). Improving Quality Control of Directional Survey Data With Continuous Inertial Navigation. SPE Drilling Engineering. 7(2). 100–106. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026